Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Colon cancer: what is new in 2004?].
André T, Louvet C, de Gramont A. André T, et al. Bull Cancer. 2004 Jan;91(1):75-80. Bull Cancer. 2004. PMID: 14975808 Free article. Review. French.
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.
Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, André T, Zaniboni A, Ducreux M, Aitini E, Taïeb J, Faroux R, Lepere C, de Gramont A; GERCOR; GISCAD. Louvet C, et al. Among authors: andre t. J Clin Oncol. 2005 May 20;23(15):3509-16. doi: 10.1200/JCO.2005.06.023. J Clin Oncol. 2005. PMID: 15908661 Clinical Trial.
Current issues in adjuvant treatment of stage II colon cancer.
André T, Sargent D, Tabernero J, O'Connell M, Buyse M, Sobrero A, Misset JL, Boni C, de Gramont A. André T, et al. Ann Surg Oncol. 2006 Jun;13(6):887-98. doi: 10.1245/ASO.2006.07.003. Epub 2006 Apr 14. Ann Surg Oncol. 2006. PMID: 16614880 Review.
Colon cancer.
Rougier P, Andre T, Panis Y, Colin P, Stremsdoerfer N, Laurent-Puig P. Rougier P, et al. Among authors: andre t. Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S24-2S29. Gastroenterol Clin Biol. 2006. PMID: 17151560 Free article. Review. No abstract available.
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.
Lièvre A, Bachet JB, Boige V, Cayre A, Le Corre D, Buc E, Ychou M, Bouché O, Landi B, Louvet C, André T, Bibeau F, Diebold MD, Rougier P, Ducreux M, Tomasic G, Emile JF, Penault-Llorca F, Laurent-Puig P. Lièvre A, et al. Among authors: andre t. J Clin Oncol. 2008 Jan 20;26(3):374-9. doi: 10.1200/JCO.2007.12.5906. J Clin Oncol. 2008. PMID: 18202412
Stage II and stage III colon cancer: treatment advances and future directions.
Rousseau B, Chibaudel B, Bachet JB, Larsen AK, Tournigand C, Louvet C, André T, de Gramont A; GERCOR (French Oncology Research Group). Rousseau B, et al. Among authors: andre t. Cancer J. 2010 May-Jun;16(3):202-9. doi: 10.1097/PPO.0b013e3181ddc5bf. Cancer J. 2010. PMID: 20526097 Review.
[Operable colon cancer: initial strategy].
André T, Tuvignon N, Taieb J, Vaillant JC, Hannoun L, de Gramont A. André T, et al. Rev Prat. 2010 Oct 20;60(8):1089-93. Rev Prat. 2010. PMID: 21197740 French.
544 results